Literature DB >> 10517928

Spirochetal infection of the nervous system.

L B Estanislao1, A R Pachner.   

Abstract

Neurologic infection is a characteristic feature of spirochetes. The neurologic manifestations of spirochetal infection are a source of continuing public concern: Lyme neuroborreliosis in endemic areas, neurosyphilis in HIV infected patients, and neuroborreliosis during outbreaks of relapsing fever. These are reviewed in this article. The techniques for diagnosis and recommendations in the management of these infections are also discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517928     DOI: 10.1016/s0733-8619(05)70166-3

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  5 in total

1.  Lyme neuroborreliosis presenting as the syndrome of inappropriate antidiuretic hormone secretion.

Authors:  Michael P Perkins; Nathan Shumway; William L Jackson
Journal:  MedGenMed       Date:  2006-09-19

Review 2.  A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease.

Authors:  Gary P Wormser; Franc Strle; Eugene D Shapiro; Raymond J Dattwyler; Paul G Auwaerter
Journal:  Diagn Microbiol Infect Dis       Date:  2016-11-12       Impact factor: 2.803

3.  The role of infections in the pathogenesis and course of multiple sclerosis.

Authors:  Siddharama Pawate; Subramaniam Sriram
Journal:  Ann Indian Acad Neurol       Date:  2010-04       Impact factor: 1.383

4.  Lyme disease associated with Alzheimer's disease.

Authors:  Laurence Meer-Scherrer; Chien Chang Loa; Martin E Adelson; Eli Mordechai; Johannes Alexander Lobrinus; Brian A Fallon; Richard C Tilton
Journal:  Curr Microbiol       Date:  2006-03-09       Impact factor: 2.188

Review 5.  Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis: A New Mechanistic Pathway.

Authors:  Majid Ghareghani; Russel J Reiter; Kazem Zibara; Naser Farhadi
Journal:  Front Immunol       Date:  2018-10-30       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.